Green tea extract for prevention of prostate cancer progression in patients on active surveillance.

ABSTRACT:

Background

Active surveillance (AS) has evolved as a management strategy for men with low grade prostate cancer (PCa). However, these patients report anxiety, doubts about the possible progression of the disease as well as higher decisional conflict regarding selection of active surveillance, and have been reported to ultimately opt for treatment without any major change in tumor characteristics. Currently, there is a paucity of research that systematically examines alternate strategies for this target population.

Methods

We conducted a review the evidence from epidemiological, in vitro, preclinical and early phase trials that have evaluated green tea catechins (GTC) for secondary chemoprevention of prostate cancer, focused on men opting for active surveillanceof low

SUBMITTER: Kumar NB 

PROVIDER: S-EPMC6340872 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature